In breast cancer pathology, CXCL12 derived from various tissues, including bone tissue, preferentially recruits cancer cells expressing CXCR4 and promotes their metastasis to those tissues16, 17, suggesting that CXCR4 suppression in breast cancer cells might be a strategy to decrease bone metastasis. Here, CXCL12 is linked to cancer.